Aspira Womens Health Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following exhibits are filed or incorporated by reference with this report as indicated below:
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit · Filing · Filed | ||||||
| Number | Exhibit Description | Form | File No. | Exhibit | Date | Herewith |
| 3.1 | Fourth Amended and Restated Certificate of Incorporation of Vermillion, Inc. dated January 22, 2010 | 8-K | 000-31617 | 3.1 | January 25, 2010 | |
| 3.2 | Certificate of Amendment of Fourth Amended and Restated Certificate of Incorporation, effective June 19, 2014 | 10-Q | 001-34810 | 3.2 | August 14, 2014 | |
| 3.3 | Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation of Vermillion, Inc. dated June 11, 2020 | 8-K | 001-34810 | 3.1 | June 11, 2020 | |
| 3.4 | Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation, as amended February 6, 2023 | 8-K | 001-34810 | 3.1 | February 7, 2023 | |
| 3.5 | Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock | 8-K | 001-34810 | 4.1 | April 17, 2018 | |
| 3.6 | Amended and Restated Bylaws of Aspira Women's Health Inc., effective February 23, 2022 | 8-K | 001-34810 | 3.1 | February 28, 2022 | |
| 3.7 | Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation, as amended May 11, 2023 | 8-K | 001-34810 | 3.1 | May 11, 2023 | |
| 10.1* | Employment Agreement between Aspira Women's Health Inc. and Sandra Milligan effective April 1, 2024 | 8-K | 001-34810 | 10.1 | March 21, 2024 | |
| 10.2* | First Amendment to Employment Agreement between Aspira Women's Health Inc. and Torsten Hombeck, dated March 20, 2024 | 8-K | 001-34810 | 10.1 | March 25, 2024 | |
| 31.1 | Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | √ | ||||
| 31.2 | Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | √ | ||||
| 32.1** | Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | √√ | ||||
| 101.INS | Inline XBRL Instance Document - (the instant document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). | √ | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents | √ | ||||
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | √ | ||||
√Filed herewith
√√Furnished herewith
*Management contract or compensation plan or arrangement.
**The certification attached as Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Form 10-Q), irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.